Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ochanya Idoko"'
Autor:
Oluwafemi David Alo, Babajide Oluseyi Daini, Olugbenga K. Omisile, Ebere Joy Ubah, Odunayo Esther Adelusi, Ochanya Idoko-Asuelimhen
Publikováno v:
BMC Women's Health, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background The population of Nigeria is estimated at over 190 million and it is projected to increase by 44% between 2015 and 2030. However, less than one-quarter of women within reproductive age in Nigeria uses modern contraceptive methods
Externí odkaz:
https://doaj.org/article/7c98e73fa83e457e8b8ac819ba991a18
Autor:
Kingsley Chinedu Okafor, David Victor Omeiza, Lucy Ochanya Idoko, Effiong Anne Inyangobong, Ochuma Emmanuel Unubi, Amos Paul Bassi
Publikováno v:
Open Journal of Obstetrics and Gynecology. 12:814-831
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::096e486efb9f1f77d8fdf4f178b2e577
https://doi.org/10.4236/ojog.2022.128069
https://doi.org/10.4236/ojog.2022.128069
Autor:
Odunayo Esther Adelusi, Oluwafemi David Alo, Olugbenga K. Omisile, Ebere Joy Ubah, Ochanya Idoko-Asuelimhen, Babajide Oluseyi Daini
Publikováno v:
BMC Women's Health, Vol 20, Iss 1, Pp 1-9 (2020)
BMC Women's Health
BMC Women's Health
Background The population of Nigeria is estimated at over 190 million and it is projected to increase by 44% between 2015 and 2030. However, less than one-quarter of women within reproductive age in Nigeria uses modern contraceptive methods despite i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c60a742ec7ed89c37d7167383528997c
https://doi.org/10.1186/s12905-020-01059-6
https://doi.org/10.1186/s12905-020-01059-6
Autor:
Emeka Okechukwu, Kwasi Torpey, Bolatito Aiyenigba, Ochanya Idoko, Chiho Suzuki, Solomon Odafe, Otto Chabikuli, Hadiza Khamofu, Titilope Badru, Obinna Onyekwena
Publikováno v:
Journal of the International AIDS Society
Introduction: Clinical outcome is an important determinant of programme success. This study aims to evaluate patients’ baseline characteristics as well as level of care associated with lost to follow-up (LTFU) and mortality of patients on antiretro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0863d79060bb6e6e483a8f8325f68198
http://europepmc.org/articles/PMC3494164
http://europepmc.org/articles/PMC3494164